Therefore, the repression of both miR-150 and miR-34α by MYC-activating aberrations in combination with TP53 deletion/mutation, which also represses miR-34α and which are both very common in Richter’s transformation of CLL, could lead to prominent BCR signaling upregulation. The gene discussed is MYC; the disease is B-cell chronic lymphocytic leukemia.